Published in Proc Soc Exp Biol Med on November 01, 1990
Management of deliberate self poisoning in adults in four teaching hospitals: descriptive study. BMJ (1998) 3.68
Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet (1999) 3.11
Medical services in social HMOs: a reply to Harrington et al. Gerontologist (1995) 2.43
Deliberate self harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition. BMJ (1998) 2.23
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology (2008) 2.17
Human epidermal cell cultures: growth and differentiation in the absence of differentiation in the absence of dermal components or medium supplements. Proc Natl Acad Sci U S A (1979) 2.16
Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA. Genes Brain Behav (2007) 1.86
Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology (1989) 1.63
Suggestive linkage of developmental dyslexia to chromosome 1p34-p36. Lancet (1993) 1.51
Usefulness of a standard battery of laboratory tests in investigating chronic fatigue in adults. Fam Pract (1989) 1.45
Prospective study of school injuries: incidence, types, related factors and initial management. Can Med Assoc J (1983) 1.44
Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia. Am J Med (1992) 1.41
A disease in dogs resembling human pemphigus vulgaris: case reports. J Am Vet Med Assoc (1975) 1.40
Human peripheral lymphocytes bearing both B-cell complement receptors and T-cell characteristics for sheep erythrocytes detected by a mixed rosette method. Clin Exp Immunol (1974) 1.40
Homogenous rabbit 7S anti-IgG with antibody specificity for peptidoglycan. J Exp Med (1973) 1.28
Alzheimer Disease Assessment Scale: a subtest analysis. Alzheimer Dis Assoc Disord (1992) 1.27
Situational approach to the assessment of social competence in children. J Consult Clin Psychol (1985) 1.27
Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med (1997) 1.24
De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Int J Oncol (2008) 1.19
Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. Blood (1980) 1.18
Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation (1992) 1.16
The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood (1996) 1.14
Outcomes and procedures in low risk birth: a comparison of hospital and birth center settings. Birth (1987) 1.14
A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. J Clin Oncol (1988) 1.13
Human lymphocytes bearing both receptors for complement components and SRBC. Clin Immunol Immunopathol (1975) 1.12
Studies of the presence of membrane receptors for complement, IgG and the sheep erythrocyte rosetting capacity on the same human lymphocytes. Eur J Immunol (1976) 1.12
Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cells. Int J Oncol (2006) 1.11
Changes of cellular markers during differentiation of HL-60 promyelocytes to macrophages as induced by T lymphocyte conditioned medium. Leuk Res (1981) 1.11
Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. Carcinogenesis (2006) 1.10
Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol Carcinog (2007) 1.09
Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci U S A (1993) 1.07
Learned changes of feeding behavior in Aplysia in response to edible and inedible foods. J Neurosci (1986) 1.06
What happens to medical patients with psychiatric disorder? J Psychosom Res (1988) 1.06
The analgesic efficacy of patient-controlled ropivacaine instillation after Cesarean delivery. Anesth Analg (2000) 1.06
Medical ethics the Japanese way. Hastings Cent Rep (1985) 1.02
Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic disease. Cancer Res (1982) 1.01
Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells. Cancer Res (1977) 1.00
Forward and reverse selection for longevity in Drosophila is characterized by alteration of antioxidant gene expression and oxidative damage patterns. Exp Gerontol (2000) 1.00
Life-threatening complications of empiric ceftriaxone therapy for 'seronegative Lyme disease'. South Med J (1991) 0.99
Prophylactic heparin therapy in acute promyelocytic leukemia. Cancer (1978) 0.98
Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. Cancer Treat Rep (1983) 0.97
Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies. J Clin Invest (1990) 0.96
Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia. Blood (1999) 0.96
Refining the genetic location of the gene for X linked hydrocephalus within Xq28. J Med Genet (1993) 0.95
Isolation and immunochemical characterization of rabbit 7S anti-IgG with restricted heterogeneity. J Exp Med (1973) 0.95
Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment. Blood (1982) 0.94
Is childhood sexual abuse really increasing in prevalence? An analysis of the evidence. Pediatrics (1991) 0.93
Manifestations of Whipple's disease in the posterior segment of the eye. Arch Ophthalmol (1984) 0.92
Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer (1986) 0.92
Neuropsychological test development and normative data on Hispanics. Arch Clin Neuropsychol (1999) 0.91
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine. J Clin Oncol (1992) 0.90
Homoharringtonine is safe and effective for patients with acute myelogenous leukemia. Leukemia (1992) 0.90
Induction of in vitro proliferation and maturation of human aneuploid myelogenous leukemic cells. J Exp Med (1982) 0.90
General hospital services for deliberate self-poisoning: an expensive road to nowhere? Postgrad Med J (1999) 0.89
Confirmation of association between expanded CAG/CTG repeats and both schizophrenia and bipolar disorder. Psychol Med (1996) 0.89
Human T lymphocytes and myeloid colony forming cells share common antigen. Exp Hematol (1980) 0.89
Lymphoblastic lymphoma in adults. J Clin Oncol (1986) 0.89
Modulation of erythropoiesis by novel human bone marrow cytochrome P450-dependent metabolites of arachidonic acid. Blood (1991) 0.89
Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry (1997) 0.88
Culture versus biology: children's attitudes toward thinness and fatness. Pediatrics (1988) 0.88
Separation of antibody helper and antibody suppressor human T cells by using soybean agglutinin. Proc Natl Acad Sci U S A (1980) 0.88
Cellular immunity of mice to Leishmania donovani in vitro: lymphokine-mediated killing of intracellular parasites in macrophages. Proc Natl Acad Sci U S A (1981) 0.88
Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome. Blood (1983) 0.87
Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia. J Clin Oncol (1993) 0.87
Human leukemia cell maturation induced by a T-cell lymphokine isolated from medium conditioned by normal lymphocytes. Proc Natl Acad Sci U S A (1985) 0.87
Psychiatric problems among medical admissions. Int J Psychiatry Med (1991) 0.87
The McMaster School Injury Study. 1: Overview of methods. Can J Public Health (1983) 0.87
Delineation of the development of T lymphocytes from leukemic null lymphocytes upon induction by conditioned medium. Cell Immunol (1980) 0.87
Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation (review). Int J Oncol (2010) 0.87
Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines. Neoplasia (2001) 0.87
Psychosocial and pharmacological treatment of patients following deliberate self-harm: the methodological issues involved in evaluating effectiveness. Suicide Life Threat Behav (2001) 0.86
Growth regulation and cellular changes during differentiation of human prostatic cancer LNCaP cells as induced by T lymphocyte-conditioned medium. Exp Cell Res (1995) 0.86
Identical longevity phenotypes are characterized by different patterns of gene expression and oxidative damage. Exp Gerontol (2000) 0.85
Apoptotic cell death during treatment of leukemias. Leuk Lymphoma (1994) 0.85
Deficient histone acetylation and excessive deacetylase activity as epigenomic marks of prostate cancer cells. Int J Oncol (2009) 0.85
Social information processing and sociometric status: sex, age, and situational effects. J Abnorm Child Psychol (1987) 0.85
Suppression of lymphocyte activation and functions by a leukemia cell-derived inhibitor. Proc Natl Acad Sci U S A (1986) 0.85
Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonist. Cancer Lett (1995) 0.85
Traumatic chylous knee effusion. Ann Rheum Dis (1985) 0.84
Variables affecting long-term memory of learning that a food is inedible in Aplysia. Behav Neurosci (1991) 0.84
Establishment of new human prostatic cancer cell line (JCA-1). Urology (1990) 0.84
The McMaster CME Society. J Med Educ (1982) 0.84
The phenylhexyl isothiocyanate induces apoptosis and inhibits leukemia cell growth in vivo. Oncol Rep (2006) 0.84
Differentiation antigens of HL-60 promyelocytes during induced maturation. Cancer Res (1984) 0.84
Micrognathia-prenatal ultrasonographic diagnosis. Int J Gynaecol Obstet (1983) 0.83
Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia. Leukemia (1992) 0.83
An analysis of lymphocytes with both T-cell marker and IgG or complement receptors in patients with X-linked agammaglobulinemia. Clin Immunol Immunopathol (1976) 0.83
Control of cell differentiation during proliferation. I. Monocytic differentiation of HL-60 promyelocytes. Exp Cell Res (1983) 0.83
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone). Blood (1982) 0.83
Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone. J Clin Oncol (1996) 0.82
Malignant lymphomas in a population at risk for acquired immune deficiency syndrome. Cancer (1987) 0.82
Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults. Blood (1988) 0.82